A yeast protein fragment complementation assay (PCA) system based on dihydrofolate reductase (DHFR) is difficult to be operated because it is not as sensitive to trimethoprim (TMP) as the system using a prokaryotic microorganism. Here, the PCA system using DHFR, specific inhibitors, and a substrate in the yeast Saccharomyces cerevisiae was newly developed. As a model, the human oncoprotein Ras and the Ras-binding domain (RBD) of Raf-1 were individually and genetically fused to DHFR fragment, and each genetic construct was coexpressed under the control of the GAL1 promoter. An interaction between Ras and RBD could be evaluated on the basis of cell proliferation. To establish the experimental conditions for the yeast PCA system based on the DHFR reconstitution, we examined yeast host strains and the concentration of inhibitory additives to prevent endogenous DHFR activity, namely, TMP and sulfanilamide, and the substrate of DHFR, namely, folic acid. The transformant harboring wild-type Ras or its variants showed positive interaction signals, and the order of interactions for combination corresponded to the results of other in vitro assays. Moreover, combinatorial mutated Ras-binding domains were constructed, and the interaction of RBDs with Ras using this yeast PCA system was examined. As a result, various types of mutated clone for RBD were obtained. These demonstrations suggest that the yeast PCA system based on DHFR can be one of good, convenient, and inexpensive tools for investigating eukaryotic protein–protein interactions in vivo.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Amyes SG (1982) Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12. Antimicrob Agents Chemother 21:288–293
Appleman JR, Prendergast N, Delcamp TJ, Freisheim JH, Blakley RL (1988) Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. J Biol Chem 263:10304–10313
Brophy VH, Vasquez J, Nelson RG, Forney JR, Rosowsky A, Sibley CH (2000) Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae. Antimicrob Agents Chemother 44:1019–1028
Chien CT, Bartel PL, Sternglanz R, Fields S (1991) The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88:9578–9582
Chuang E, Barnard D, Hettich L, Zhang XF, Avruch J, Marshall MS (1994) Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol 14:5318–5325
Ding Z, Liang J, Lu Y, Yu Q, Songyang Z, Lin SY, Mills GB (2006) A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc Natl Acad Sci USA 103:15014–15019
Dove SK, McEwen RK, Mayes A, Hughes DC, Beggs JD, Michell RH (2002) Vac14 controls PtdIns(3,5)P(2) synthesis and Fab1-dependent protein trafficking to the multivesicular body. Curr Biol 12:885–893
Eglen RM, Singh R (2003) Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening. Comb Chem High Throughput Screen 6:381–387
Fields S, Song O (1989) A novel genetic system to detect protein–protein interactions. Nature 340:245–246
Fridman M, Maruta H, Gonez J, Walker F, Treutlein H, Zeng J, Burgess A (2000) Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras. J Biol Chem 275:30363–30371
Game JC, Little JG, Haynes RH (1975) Yeast mutants sensitive to trimethoprim. Mutat Res 28:175–182
Goishi K, Mizuno K, Nakanishi H, Sasaki T (2004) Involvement of Rab27 in antigen-induced histamine release from rat basophilic leukemia 2H3 cells. Biochem Biophys Res Commun 324:294–301
Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166:557–580
Herrmann C, Martin GA, Wittinghofer A (1995) Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 270:2901–2905
Huang T, Barclay BJ, Kalman TI, von Borstel RC, Hastings PJ (1992) The phenotype of a dihydrofolate reductase mutant of Saccharomyces cerevisiae. Gene 121:167–71
Ito H, Fukuda Y, Murata K, Kimura A (1983) Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153:163–168
Kuroda K, Kato M, Mima J, Ueda M (2006) Systems for the detection and analysis of protein–protein interactions. Appl Microbiol Biotechnol 71:127–136
MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T, Michnick SW, Westwick JK (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2:329–337
Michnick SW (2003) Protein fragment complementation strategies for biochemical network mapping. Curr Opin Biotechnol 14:610–617
Miyajima A, Miyajima I, Arai K, Arai N (1984) Expression of plasmid R388-encoded type II dihydrofolate reductase as a dominant selective marker in Saccharomyces cerevisiae. Mol Cell Biol 4:407–414
Mizuno K, Kitamura A, Sasaki T (2003) Rabring7, a novel Rab7 target protein with a RING finger motif. Mol Biol Cell 14:3741–3752
Neves MJ, Hohmann S, Bell W, Dumortier F, Luyten K, Ramos J, Cobbaert P, de Koning W, Kaneva Z, Thevelein JM (1995) Control of glucose influx into glycolysis and pleiotropic effects studied in different isogenic sets of Saccharomyces cerevisiae mutants in trehalose biosynthesis. Curr Genet 27:110–122
Nord O, Gustrin A, Nygren PA (2005) Fluorescent detection of beta-lactamase activity in living Escherichia coli cells via esterase supplementation. FEMS Microbiol Lett 242:73–79
Okochi N, Kato-Murai M, Kadonosono T, Ueda M (2007) Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface. Appl Microbiol Biotechnol 77:597–603
Pelletier JN, Campbell-Valois FX, Michnick SW (1998) Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc Natl Acad Sci USA 95:12141–12146
Remy I, Michnick SW (1999) Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. Proc Natl Acad Sci USA 96:5394–5399
Scheffler JE, Waugh DS, Bekesi E, Kiefer SE, LoSardo JE, Neri A, Prinzo KM, Tsao KL, Wegrzynski B, Emerson SD, Fry DC (1994) Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP. J Biol Chem 269:22340–22346
Shibasaki S, Kuroda K, Duc Nguyen H, Mori T, Zou W, Ueda M (2006) Detection of protein–protein interactions by a combination of a novel cytoplasmic membrane targeting system of recombinant proteins and fluorescence resonance energy transfer. Appl Microbiol Biotechnol 70:451–457
Subramaniam R, Desveaux D, Spickler C, Michnick SW, Brisson N (2001) Direct visualization of protein interactions in plant cells. Nat Biotechnol 19:769–772
Tajima M, Nogi Y, Fukasawa T (1985) Primary structure of the Saccharomyces cerevisiae GAL7 gene. Yeast 1:67–77
Tarassov K, Messier V, Landry CR, Radinovic S, Molina MM, Shames I, Malitskaya Y, Vogel J, Bussey H, Michnick SW (2008) An in vivo map of the yeast protein interactome. Science 320:1465–1470
Zervos AS, Gyuris J, Brent R (1993) Mxi1, a protein that specifically interacts with Max to bind Myc–Max recognition sites. Cell 72:223–232
This work was partially supported by grants from Chemicals Evaluation and Research Institute, Japan.
About this article
Cite this article
Shibasaki, S., Sakata, K., Ishii, J. et al. Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives. Appl Microbiol Biotechnol 80, 735–743 (2008). https://doi.org/10.1007/s00253-008-1624-x
- Saccharomyces cerevisiae